AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL
· Real-Time Price · USD
4.58
0.08 (1.78%)
At close: Aug 15, 2025, 3:59 PM
4.59
0.22%
After-hours: Aug 15, 2025, 07:59 PM EDT
AbCellera Biologics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 159.27M | 156.32M | 126.64M | 148.31M | 123.57M | 133.32M | 172.42M | 179.75M | 193.02M | 386.54M | 371.97M | 790.62M | 545.72M | 476.14M | 517.69M | 792.57M | 685.79M |
Short-Term Investments | 446M | 469.29M | 516.5M | 522.04M | 574.45M | 627.26M | 613.42M | 615.95M | 603.48M | 499.95M | 496.23M | 231.65M | 240.34M | 246.84M | 235.78M | n/a | n/a |
Long-Term Investments | 81.57M | 82.3M | 84.08M | 130.76M | 122.09M | 65.94M | 62.89M | 58.79M | 57.58M | 72.52M | 66.72M | 65.82M | 58.88M | 50.31M | 47.51M | 42.7M | 32.19M |
Other Long-Term Assets | 61.56M | 96.54M | 134.22M | 57.81M | 54.43M | 94.24M | 80.69M | 113.45M | 89.84M | 46.33M | 49.07M | 43.84M | 43.39M | 23.23M | 31.62M | 15.95M | 9.55M |
Receivables | 126.61M | 92.13M | 63.24M | 67.7M | 68.78M | 64.38M | 75.48M | 86.23M | 99.57M | 103.41M | 105.96M | 52.8M | 334.4M | 160.58M | 43.63M | 65.31M | 216.69M |
Inventory | n/a | n/a | n/a | n/a | 738K | 1.11M | 1.19M | 1.45M | 1.45M | 1.53M | 25M | 25M | 25M | 1.67M | 1.33M | 1.21M | 1.21M |
Other Current Assets | 33.1M | 33.63M | 36.51M | 33.49M | 21.41M | 45.91M | 25M | 25M | 25M | 25M | 46.5M | 43.89M | 28.92M | 39.28M | n/a | n/a | n/a |
Total Current Assets | 764.98M | 751.37M | 742.88M | 771.55M | 813.95M | 871.99M | 919.52M | 930.74M | 940.65M | 1.03B | 1.05B | 1.14B | 1.17B | 929.8M | 803.75M | 864M | 907.98M |
Property-Plant & Equipment | 347.1M | 340.43M | 331.26M | 318.88M | 306.08M | 287.7M | 277.21M | 259.64M | 233.19M | 217.25M | 200.6M | 149.18M | 122.05M | 111.62M | 91.58M | 87.48M | 34.62M |
Goodwill & Intangibles | 89M | 89.92M | 100.38M | 133.47M | 166.54M | 168.23M | 171.88M | 174.55M | 176.65M | 179.31M | 190.35M | 190.99M | 193.59M | 196.2M | 198.28M | 141.72M | 144.19M |
Total Long-Term Assets | 579.23M | 609.18M | 649.95M | 640.93M | 649.15M | 616.11M | 592.67M | 606.43M | 557.27M | 515.42M | 506.74M | 449.83M | 417.91M | 388.77M | 368.99M | 287.85M | 220.54M |
Total Assets | 1.34B | 1.36B | 1.39B | 1.41B | 1.46B | 1.49B | 1.51B | 1.54B | 1.5B | 1.54B | 1.55B | 1.59B | 1.59B | 1.32B | 1.17B | 1.15B | 1.13B |
Account Payables | 32.8M | 34.35M | 34.8M | 26.59M | 26.91M | 28.6M | 17.43M | 21.02M | 17.57M | 14.83M | 9.32M | 10.31M | 10.35M | 14.92M | 8.91M | 5.61M | 3.58M |
Deferred Revenue | 26M | 21.18M | 5.58M | 6.4M | 10.56M | 26.07M | 23.86M | 15.06M | 18.39M | 27.9M | 13.1M | 10.39M | 14.24M | 7.54M | 10.12M | 10.57M | 11.31M |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | n/a | 8.09M | 28.08M | 27.43M | 59.03M | 50.48M | 57.02M | 57.97M | 45.97M | n/a | 50.35M | 84.81M | 72.86M | 54.85M | 17.52M | 43.2M | 41.94M |
Total Current Liabilities | 75.4M | 76.61M | 79.57M | 70.38M | 104.88M | 119.01M | 110.24M | 118.91M | 89.59M | 118.32M | 106.05M | 221.14M | 213.42M | 120.68M | 49.55M | 69.76M | 88.39M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 1.62M | 1.47M | 5.96M | 10.79M | 10.8M | 10.82M | 10.36M | 8.11M | 18.7M | 19.14M | 28.25M | 27.61M | 34.05M | 37.62M | 46.64M | 11.27M | 10.31M |
Total Long-Term Liabilities | 245.83M | 227.86M | 235.17M | 231.13M | 228.3M | 216.76M | 219.18M | 223.43M | 199.83M | 189.31M | 196.19M | 159.79M | 171.36M | 172.16M | 169.79M | 114.42M | 83M |
Total Liabilities | 321.23M | 304.47M | 314.73M | 301.51M | 333.18M | 335.78M | 329.42M | 342.34M | 289.42M | 307.63M | 302.24M | 380.93M | 384.78M | 292.84M | 219.34M | 184.18M | 171.4M |
Total Debt | 67.85M | 65.36M | 71.4M | 72.05M | 73.61M | 77.38M | 80.76M | 84.03M | 83.13M | 82.26M | 76.11M | 36.78M | 40.28M | 40.06M | 30.06M | 33.24M | 18.51M |
Common Stock | 790.07M | 777.17M | 772.83M | 769.97M | 764.56M | 753.2M | 747.91M | 744.76M | 742.82M | 734.37M | 730.43M | 726.83M | 725.75M | 722.43M | 718.09M | 714.76M | 711.14M |
Retained Earnings | 71.31M | 116.93M | 151.14M | 202.25M | 239.18M | 279.79M | 326.94M | 355.55M | 386.07M | 426.19M | 456.08M | 429.45M | 436.24M | 267.67M | 207.72M | 229.1M | 231.42M |
Comprehensive Income | -7M | -4.38M | -1.23M | -2.07M | -1.82M | -1.72M | -1.46M | -1.9M | -2.02M | -1.39M | -717K | 576K | 787K | 280K | 644K | 2.15M | n/a |
Shareholders Equity | 1.02B | 1.06B | 1.08B | 1.11B | 1.13B | 1.15B | 1.18B | 1.19B | 1.21B | 1.23B | 1.25B | 1.21B | 1.21B | 1.03B | 953.4M | 967.68M | 957.12M |
Total Investments | 527.57M | 551.59M | 600.58M | 652.81M | 696.54M | 693.2M | 676.3M | 674.74M | 661.06M | 572.47M | 562.95M | 297.48M | 299.22M | 297.15M | 283.29M | 42.7M | 32.19M |